Ouvrages publiés en collaboration (1)
  1. 1. Van Houtte, P., Charlier, F., Moretti, L., & Van Gestel, D. (2020). Radiotherapy an Alternative to Surgery. doi:10.5772/intechopen.94486
    2.   Articles dans des revues avec comité de lecture (72)
  2. 1. Sant’Angelo, D., Descamps, G., Lecomte, V., Stanicki, D., Penninckx, S., Dragan, T., Van Gestel, D., Laurent, S., & Journe, F. (2025). Therapeutic Approaches with Iron Oxide Nanoparticles to Induce Ferroptosis and Overcome Radioresistance in Cancers. Pharmaceuticals, 18(3), 325. doi:10.3390/ph18030325
  3. 2. de Bakker, T., Maes, A., Dragan, T., Martinive, P., Penninckx, S., & Van Gestel, D. (2025). Strategies to Overcome Intrinsic and Acquired Resistance to Chemoradiotherapy in Head and Neck Cancer. Cells, 14(1), 18. doi:10.3390/cells14010018
  4. 3. Dragan, T., Soussy, K., Beauvois, S., Lefebvre, Y., Lemort, M., Ozalp, E., Gulyban, A., Burghelea, M., Wardi, C. A., Marin, C., Benkhaled, S., & Van Gestel, D. (2024). Enhanced head and neck radiotherapy target definition through multidisciplinary delineation and peer review: A prospective single-center study. Clinical and Translational Radiation Oncology, 48, 100837. doi:10.1016/j.ctro.2024.100837
  5. 4. Schoenauen, L., Stubbe, F. X., Van Gestel, D., Penninckx, S., & Heuskin, A.-C. (2024). C. elegans: A potent model for high-throughput screening experiments investigating the FLASH effect. Clinical and Translational Radiation Oncology, 45, 100712. doi:10.1016/j.ctro.2023.100712
  6. 5. De Caluwe, A., Romano, E., Poortmans, P., Gombos, A., Agostinetto, E., Marta, G. N., Denis, Z., Drisis, S., Vandekerkhove, C., Desmet, A., Philippson, C., Craciun, L., Veys, I., Larsimont, D., Paesmans, M., Van Gestel, D., Salgado, R., Sotiriou, C., Piccart-Gebhart, M., Ignatiadis, M., & Buisseret, L. (2023). First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial. Journal for ImmunoTherapy of Cancer, 11(12). doi:10.1136/jitc-2023-007279
  7. 6. Mootassim-Billah, S., Van Nuffelen, G., Schoentgen, J., De Bodt, M. M., & Van Gestel, D. (2023). Assessment of radio(chemo)therapy‑related dysphagia in head and neck cancer patients based on cough‑related acoustic features: a prospective phase II national clinical trial (ACCOUGH‑P/A trial). Trials.
  8. 7. Burghelea, M., Bakkali Tahiri, J., Dhont, J., Kyndt, M., Gulyban, A., Szkitsak, J., Bogaert, E., Van Gestel, D., & Reynaert, N. (2023). Results of a multicenter 4D computed tomography quality assurance audit: Evaluating image accuracy and consistency. Physics and Imaging in Radiation Oncology, 28, 100479. doi:10.1016/j.phro.2023.100479
  9. 8. Van Houtte, P., & Van Gestel, D. (2023). A quality assurance program: a clear necessity in modern oncology care. Precision cancer medicine, 6, 7921. doi:10.21037/pcm-23-14
  10. 9. Sabbah, M., Najem, A., Vanderkerkhove, C., Kert, F., Jourani, Y., Journe, F., Awada, A., Van Gestel, D., Ghanem, G. E., & Krayem, M. (2023). The benefit of co-targeting PARP-1 and c-Met on the efficacy of radiotherapy in wild type BRAF melanoma. Frontiers in medicine, 10. doi:10.3389/fmed.2023.1149918
  11. 10. Mootassim-Billah, S., Schoentgen, J., De Bodt, M. M., Roper, N., Digonnet, A., Le Tensorer, M., Van Nuffelen, G., & Van Gestel, D. (2023). Acoustic Analysis of Voluntary Coughs, Throat Clearings, and Induced Refexive Coughs in a Healthy Population. Dysphagia.
  12. 11. Iliadi Anagnostaki, C., Verset, L., Bouchart, C., Martinive, P., Van Gestel, D., & Krayem, M. (2023). The current understanding of the immune landscape relative to radiotherapy across tumor types. Frontiers in Immunology, 14. doi:10.3389/fimmu.2023.1148692
    13. << Précédent 1 2 3 4 5 6 7 8 9 Suivant >>